Boltz partners with Bristol Myers Squibb to bring its models into drug discovery at GTC
GabriCorso · x · 2026-10-21
Announced at NVIDIA GTC: the Boltz team is partnering with Bristol Myers Squibb to integrate the latest Boltz biomolecular models into BMS's drug discovery workflows — another sign of AI-for-science models moving into big pharma pipelines.
Related event: Boltz Partners with Bristol Myers Squibb to Accelerate Drug Discovery(4 posts)→
More from Apps
- Indie hacker ships 8 email product features in one drop with Opus, shares inbox open-rate data — marclou · 2026-10-21
- Solo dev runs 6,000+ unattended news episodes in 19 months — eval loops, not models — jwdNyc · 2026-10-21
- Prototyping physical products with Grok Bot: from sketches to RFQs — elonmusk · 2026-10-21
- Obsidian plugin Qiaomu AI RSS adds Chinese transcripts of 5 top AI podcasts — vista8 · 2026-10-21
- Honen launches AI training product with NVIDIA to reach 250,000 learners — floguo · 2026-10-21
- ChatGPT desktop app called out for sluggish rendering and slow image loading — mark_k · 2026-10-21